Benjamin Jen
Director/Board Member bei JIANGSU CNANO TECHNOLOGY CO., LTD.
Profil
Benjamin C.
M.
Jen is the founder of GRC Sinogreen Investment Advisor (Beijing) Co. Ltd.
founded in 2005, where he holds the title of Managing Partner.
Currently, he holds the position of Director at Jiangsu Cnano Technology Co., Ltd.
since 2015, Director at Applied BioCode Corp.
since 2016, and Director at Applied BioCode, Inc. He previously held the position of Director at Applied Optoelectronics, Inc. Mr. Jen's education history includes an undergraduate degree from the University of Missouri and an MBA from the Massachusetts Institute of Technology.
Aktive Positionen von Benjamin Jen
| Unternehmen | Position | Beginn |
|---|---|---|
| JIANGSU CNANO TECHNOLOGY CO., LTD. | Director/Board Member | 01.03.2015 |
| APPLIED BIOCODE CORPORATION | Director/Board Member | 29.09.2016 |
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd.
 GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen. | Founder | 01.01.2005 |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Director/Board Member | - |
Ehemalige bekannte Positionen von Benjamin Jen
| Unternehmen | Position | Ende |
|---|---|---|
| APPLIED OPTOELECTRONICS, INC. | Director/Board Member | 27.02.2013 |
Ausbildung von Benjamin Jen
| University of Missouri | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| APPLIED OPTOELECTRONICS, INC. | Electronic Technology |
| JIANGSU CNANO TECHNOLOGY CO., LTD. | Producer Manufacturing |
| APPLIED BIOCODE CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd.
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen. | Finance |
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
